Examiner: TAYLOR, LIA ELAN

Tech Center 1600 • Art Units: 1641 1642 1644 1675

This examiner grants 64% of resolved cases

Performance Statistics

64.5%

Allow Rate

+4.5% vs TC avg

234

Total Applications

+29.4%

Interview Lift

1152

Avg Prosecution Days

Based on 186 resolved cases, 2023–2026

2.4%

§101 Eligibility

13.3%

§102 Novelty

24.8%

§103 Obviousness

34.7%

§112 Clarity

App #	Title	Status	Assignee
18462320	METHOD OF TREATING AN ALLERGY WITH ALLERGEN-SPECIFIC MONOCLONAL ANTIBODIES	Non-Final OA	REGENERON PHARMACEUTICALS, INC.
18257409	CONJUGATED FUMONISIN TO PROTECT AGAINST MYCOTOXICOSIS	Final Rejection	INTERVET INC.
18106903	TREATMENT OF AN ISCHEMIC HEART DISEASE	Final Rejection	Yeda Research and Development Co. Ltd.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.